migraine progression
Recently Published Documents


TOTAL DOCUMENTS

19
(FIVE YEARS 1)

H-INDEX

10
(FIVE YEARS 0)

2021 ◽  
Vol 12 ◽  
Author(s):  
Mansoureh Togha ◽  
Zeinab Ghorbani ◽  
Samira Ramazi ◽  
Fahime Zavvari ◽  
Fariba Karimzadeh

Objectives: This study aimed to investigate the role of serum levels of transient receptor potential cation channel subfamily V member 1 (TRPV1), vasoacive intestinal peptide (VIP), and pituitary adenylate cyclase-activating polypeptide (PACAP) in the development and also the transformation of migraine in patients suffering from migraine.Methods: Eighty-nine participants with a mean age of 39 years were divided into 23 episodic migraine (EM), 36 chronic migraine (CM), and 30 healthy control groups. Demographic, anthropometric, and headache characteristic information, and also blood samples, was collected. Serum levels of TRPV1, VIP, and PACAP were measured using the enzyme-linked immunosorbent assay (ELISA) technique.Results: Based on our findings, the serum level of TRPV1 was significantly higher in CM compared to the control group (p < 0.05), whereas serum levels of VIP (p < 0.01) and PACAP (p < 0.05) in the EM group were significantly more than the control group. There was no significant difference between EM and CM groups.Conclusions: An elevation in the serum levels of TRVP1 among chronic migraineurs and increments in the levels of VIP and PACAP were observed among EM patients compared to healthy subjects. However, our data failed to demonstrate the probable role of these biomarkers in migraine progression, and more studies are needed to clarify the molecular mechanisms involved in migraine progression.



Neurology ◽  
2020 ◽  
Vol 95 (15) ◽  
pp. 707.2-708
Author(s):  
Richard B. Lipton ◽  
Kristina M. Fanning ◽  
Dawn C. Buse ◽  
Vincent T. Martin ◽  
Lee B. Hohaia ◽  
...  




Neurology ◽  
2020 ◽  
Vol 95 (15) ◽  
pp. 706.2-706
Author(s):  
James E. Siegler ◽  
Steven Galetta
Keyword(s):  


2019 ◽  
Vol 59 (7) ◽  
pp. 974-976
Author(s):  
Dawn C. Buse ◽  
Jacob D. Greisman ◽  
Khosrow Baigi ◽  
Richard B. Lipton


2019 ◽  
Vol 22 ◽  
pp. S283
Author(s):  
L. Li ◽  
L. Mueller ◽  
C. Hitchcock ◽  
R. Zyoud ◽  
J. Bell ◽  
...  


2018 ◽  
Vol 59 (3) ◽  
pp. 306-338 ◽  
Author(s):  
Dawn C. Buse ◽  
Jacob D. Greisman ◽  
Khosrow Baigi ◽  
Richard B. Lipton


Cephalalgia ◽  
2017 ◽  
Vol 38 (4) ◽  
pp. 776-785 ◽  
Author(s):  
Radhouane Dallel ◽  
Amélie Descheemaeker ◽  
Philippe Luccarini

Background A subgroup of migraineurs experience an increase in attack frequency leading to chronic migraine. Methods We assessed in rats the roles of dose and repeat administration of systemic isosorbide dinitrate (ISDN), a nitric oxide donor, on the occurrence and development of cephalic/face and extracephalic/hindpaw mechanical allodynia as a surrogate of migraine pain, and the effect of acute systemic sumatriptan and olcegepant and chronic systemic propranolol on these behavioral changes. Results A single high (H-ISDN) but not low (L-ISDN) dose of ISDN induces a reversible cephalic and extracephalic mechanical allodynia. However, with repeat administration, L-ISDN produces reversible cephalic but never extracephalic allodynia, whereas H-ISDN induces cephalic and extracephalic allodynia that are both potentiated. H-ISDN-induced cephalic allodynia thus gains persistency. Sumatriptan and olcegepant block single H-ISDN-induced behavioral changes, but only olcegepant reduces these acute changes when potentiated by repeat administration. Neither sumatriptan nor olcegepant prevent chronic cephalic hypersensitivity. Conversely, propranolol blocks repeat H-ISDN-induced chronic, but not acute, behavioral changes. Conclusions Repeated ISDN administration appears to be a naturalistic rat model for migraine progression, suitable for screening acute and preventive migraine therapies. It suggests frequent and severe migraine attacks associated with allodynia may be a risk factor for disease progression.



2017 ◽  
Vol 95 (1) ◽  
pp. 15-22
Author(s):  
Vadim A. Akhmedov ◽  
O. V. Gaus

This review article highlights the modern views of manifestations associated with Hp infection. The data are presented about the negative impact of the infection on the state of the musculoskeletal system, the development of migraine, progression of diffuse liver disease and the risk of developing liver cancer. The paper also provides information on the possible effects of Helicobacter pylori infection on the formation of halitosis, tympanosclerosis, male reproductive health disorders, colorectal cancer, Alzheimer's and Parkinson's disease, pre-eclampsia during pregnancy, and idiopathic chronic urticaria. In addition, the negative relationship between Hp infection, bronchial asthma, and inflammatory bowel disease is considered.



Pain ◽  
2014 ◽  
Vol 155 (7) ◽  
pp. 1196-1205 ◽  
Author(s):  
Nelly Boyer ◽  
Radhouane Dallel ◽  
Alain Artola ◽  
Lénaïc Monconduit


Sign in / Sign up

Export Citation Format

Share Document